Evidence map›Paper›PMID 35572519›Full record

Trial reportFrontiers in immunology2022

Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome

Eun Ran Kim, So Ra Kim, Wonhee Cho, Sang-Guk Lee, Soo Hyun Kim, Jin Hee Kim, Eunhye Choi, Jeong-Ho Kim, Je-Wook Yu, Byung-Wan Lee and 6 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT02964572. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02964572 nacompleted

Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes

Ran2016Enrolled61Registered outcomes16Posted comparisons0ConditionsType2 Diabetes MellitusArmsempagliflozin, Glimepiride
Open the trial in the graph
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Liver Brain Interactions: Focus on FGF21 a Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Eun Ran KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
So Ra KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Wonhee ChoExercise Medicine Center for Diabetes and Cancer Patients, Institute of Convergence Science (ICONS), Yonsei University, Seoul, South Korea.
Sang-Guk LeeDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Soo Hyun KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Jin Hee KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Eunhye ChoiDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Jeong-Ho KimDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Je-Wook YuBrain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
Byung-Wan LeeDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Eun Seok KangDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Bong-Soo ChaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Myung-Shik LeeDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Jin Won ChoDepartment of Systems Biology, Glycosylation Network Research Center, Yonsei University, Seoul, South Korea.
Justin Y JeonExercise Medicine Center for Diabetes and Cancer Patients, Institute of Convergence Science (ICONS), Yonsei University, Seoul, South Korea.
Yong-Ho LeeDivision of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Yonsei University · KRSeverance Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A ketogenic diet (KD) is known to have beneficial health effects. Various types of KD interventions have been applied to manage metabolic syndrome based on modification of diet parameters such as duration of intervention, macronutrient components, and total calories. Nevertheless, the beneficial health impact of isocaloric KD is largely unknown, especially in healthy subjects. The present study investigated the acute effects of a 3-day isocaloric KD. In this non-randomized intervention study, we recruited 15 healthy volunteers aged 24-38 years (7 men and 8 women) and placed them on an isocaloric KD restricting intake of carbohydrates but not energy (75% fat, 20% protein, 5% carbohydrate) for 3 days. Biochemical profiles and laboratory measurements were performed. Peripheral blood monocular cells were cultured, and measured cell stimulated cytokines. After short-term isocaloric KD, subjects lost body weight and serum free fatty acid levels were increased. These results accompanied elevated serum β-hydroxybutyrate (BHB) concentration and fibroblast growth factor 21 (FGF21) levels and improved insulin sensitivity. Regarding the direct effect of BHB on inflammasome activation, interleukin-1β (IL-1β) and tumor necrosis factor-α secretion in response to adenosine triphosphate or palmitate stimulation in human macrophages decreased significantly after isocaloric KD. In Clinical Trial Registration: clinicaltrials.gov (NCT02964572).

Indexed as

Diet, KetogenicInflammasomes3-Hydroxybutyric AcidAdultFemaleFibroblast Growth FactorsHumansMaleNLR Family, Pyrin Domain-Containing 3 ProteinYoung Adult3-Hydroxybutyric Acidfibroblast growth factor 21Fibroblast Growth FactorsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinFGF21IL-1β (interleukin 1β)isocaloricKetogenic diet (KD)NLRP3 inflammasomeβ-hydroxybutyrate

Identifiers

PMID35572519
PMCPMC9095902
OpenAlexW4285741778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.